financetom
Business
financetom
/
Business
/
Baldwin Group's Q3 revenue rises 8%, beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baldwin Group's Q3 revenue rises 8%, beats estimates
Nov 4, 2025 2:01 PM

Overview

* Baldwin Q3 revenue grows 8% to $365.4 mln, beating analyst expectations

* Adjusted EPS for Q3 at $0.31, exceeding analyst estimates

* Company reports Q3 GAAP net loss of $30.2 mln

Outlook

* Company did not provide specific guidance for future quarters or full year

Result Drivers

* ORGANIC GROWTH - Baldwin reported a 5% organic revenue growth, contributing to the overall revenue increase

* CASH FLOW IMPROVEMENT - Adjusted free cash flow increased by 26% due to debt reduction and capital optimization

* STABLE EBITDA - Adjusted EBITDA remained at $72.5 million, showing stable operational performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $365.38 $363.72

Revenue mln mln (6

Analysts

)

Q3 Beat $0.31 $0.30 (9

Adjusted Analysts

EPS )

Q3 EPS -$0.27

Q3 Beat $36.50 $35.66

Adjusted mln mln (6

Net Analysts

Income )

Q3 Net -$30.23

Income mln

Q3 Beat $72.50 $70.59

Adjusted mln mln (6

EBITDA Analysts

)

Q3 20%

Adjusted

EBITDA

Margin

Q3 $3.21

Operatin mln

g income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the multiline insurance & brokers peer group is "buy"

* Wall Street's median 12-month price target for Baldwin Insurance Group Inc ( BWIN ) is $33.50, about 33.1% above its November 3 closing price of $22.41

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment
Apr 23, 2024
03:54 PM EDT, 04/23/2024 (MT Newswires) -- Day One Biopharmaceuticals ( DAWN ) shares rose 10% in recent Tuesday trading after the company's Ojemda received accelerated approval from the US Food and Drug Administration for the treatment of patients six months and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation....
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
Apr 23, 2024
* Reaffirms full-year sales and profit forecasts * CEO says off to a good start for the year * MAT posts Q1 adj loss of 5 cents/shr vs est. of 12 cents/shr * Reports Q1 sales of $809.5 mln vs est. of $831.8 mln By Granth Vanaik April 23 (Reuters) - Mattel ( MAT ) posted a smaller-than-expected loss for...
Five Eyes countries working to fight critical minerals dumping, Canada minister says
Five Eyes countries working to fight critical minerals dumping, Canada minister says
Apr 23, 2024
TORONTO, April 23 (Reuters) - Canada and its Five Eyes Alliance partners are working on put forward a response to tackle the price manipulation of critical metals, Canada's Finance Minister Chrystia Freeland said on Tuesday. The U.S., Britain, Canada, Australia and New Zealand have what is called the Five Eyes intelligence sharing network and the finance ministers from these countries...
Analog chipmaker Texas Instruments forecasts quarterly revenue above estimates
Analog chipmaker Texas Instruments forecasts quarterly revenue above estimates
Apr 23, 2024
April 23 (Reuters) - Chipmaker Texas Instruments forecast second-quarter revenue above Wall Street estimates on Tuesday, as consumer electronics demand improved after months of declines, more than offsetting the impact from chip inventory corrections in the automotive market. The Dallas, Texas-based company expects revenue with a midpoint of $3.8 billion for the quarter, compared with analysts' average estimate of $3.77...
Copyright 2023-2026 - www.financetom.com All Rights Reserved